Kailera Therapeutics Secures $625 Million in Landmark IPO, Poised to Accelerate Obesity Pipeline Development and Challenge Market Leaders
Obesity biotech Kailera Therapeutics has successfully entered the US public market with an upsized $625 million Initial Public Offering (IPO),...
July 20, 2025